GL1X · GenesisL1 explorer

MolNFT v1 · #145815 · protein

Structure of the PTK6 kinase domain bound to a type II inhibitor 2- {[(3R,4S)-3-fluoro-1-{[4-(TRIFLUOROMETHOXY)PHENYL]ACETYL}PIPERIDIN-4- YL]OXY}-5-(1-methyl-1H-imidazol-4-YL)PYRIDINE-3-carboxamide

6CZ4 · Protein-tyrosine kinase 6: “Structure of the PTK6 kinase domain bound to a type II inhibitor 2…”. X-ray diffraction, 1 ligand (FKY), 4 pockets (best druggability 0.80). MolNFT v1 #145815 on GenesisL1: 3D structure, binding sites and…

PDB
6CZ4
Type
protein
Length
257 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein-tyrosine kinase 6
EC
2.7.10.2
UniProt
Q13882
Ligands
FKY
Pockets
4 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein-tyrosine kinase 6 (EC 2.7.10.2)protein25742% helix, 19% strandQ13882

Ligands and binding sites

  • FKY · 2-{[(3R,4S)-3-fluoro-1-{[4-(trifluoromethoxy) phenyl]acetyl}piperidin-4-yl]oxy}-5-(1-methyl-1H-imidazol-4-yl)pyridine-3-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13110.800.9041FKY
2790.470.8217empty
31330.440.7619empty
41440.430.7523empty

Compared structures

  • 6CZ4 · Structure of the PTK6 kinase domain bound to a type II inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q13882 · AlphaFold monomer V2.0 prediction for protein-tyrosine kinase 6 (Q13882) · a predicted model of the same protein · chain A against A, TM-score 0.90

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.